Soleus Capital Management as of March 31, 2024
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 91 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 15.5 | $209M | 2.2M | 94.89 | |
| United Therapeutics Corporation (UTHR) | 4.4 | $60M | 260k | 229.72 | |
| Edap Tms S A Sponsored Adr (EDAP) | 3.9 | $53M | 7.2M | 7.35 | |
| Iovance Biotherapeutics (IOVA) | 3.9 | $52M | 3.5M | 14.82 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.7 | $49M | 3.5M | 14.11 | |
| Tg Therapeutics (TGTX) | 3.6 | $48M | 3.2M | 15.21 | |
| Celcuity (CELC) | 2.8 | $37M | 1.7M | 21.60 | |
| Jasper Therapeutics Com New (JSPR) | 2.6 | $35M | 1.2M | 29.36 | |
| Neuropace (NPCE) | 2.4 | $32M | 2.4M | 13.20 | |
| Essa Pharma Com New (EPIX) | 2.3 | $31M | 3.6M | 8.49 | |
| Organogenesis Hldgs (ORGO) | 2.0 | $27M | 9.6M | 2.84 | |
| Axogen (AXGN) | 1.9 | $25M | 3.1M | 8.07 | |
| Humana (HUM) | 1.9 | $25M | 72k | 346.72 | |
| SurModics (SRDX) | 1.7 | $24M | 801k | 29.34 | |
| Revolution Medicines (RVMD) | 1.7 | $24M | 729k | 32.23 | |
| Ideaya Biosciences (IDYA) | 1.7 | $23M | 534k | 43.88 | |
| Beigene Sponsored Adr (BGNE) | 1.7 | $23M | 148k | 156.39 | |
| C4 Therapeutics Com Stk (CCCC) | 1.5 | $20M | 2.5M | 8.17 | |
| Penumbra (PEN) | 1.4 | $19M | 86k | 223.18 | |
| Verastem Com New (VSTM) | 1.3 | $18M | 1.5M | 11.80 | |
| Keros Therapeutics (KROS) | 1.3 | $18M | 274k | 66.20 | |
| Treace Med Concepts (TMCI) | 1.3 | $18M | 1.3M | 13.05 | |
| Hca Holdings (HCA) | 1.3 | $17M | 51k | 333.53 | |
| Nurix Therapeutics (NRIX) | 1.2 | $16M | 1.1M | 14.70 | |
| Castle Biosciences (CSTL) | 1.2 | $16M | 726k | 22.15 | |
| Iradimed (IRMD) | 1.2 | $16M | 362k | 43.99 | |
| Biogen Idec (BIIB) | 1.2 | $16M | 73k | 215.63 | |
| Krystal Biotech (KRYS) | 1.1 | $15M | 84k | 177.93 | |
| Vaxcyte (PCVX) | 1.1 | $14M | 208k | 68.31 | |
| Bioatla (BCAB) | 1.0 | $14M | 4.1M | 3.44 | |
| GSK Sponsored Adr (GSK) | 1.0 | $14M | 319k | 42.87 | |
| Rigel Pharmaceuticals Com New (RIGL) | 1.0 | $14M | 9.2M | 1.48 | |
| Engene Holdings (ENGN) | 1.0 | $14M | 800k | 16.95 | |
| Inari Medical Ord (NARI) | 1.0 | $13M | 277k | 47.98 | |
| Novocure Ord Shs (NVCR) | 0.8 | $11M | 696k | 15.63 | |
| Tango Therapeutics (TNGX) | 0.8 | $11M | 1.4M | 7.94 | |
| Applied Therapeutics (APLT) | 0.8 | $11M | 1.6M | 6.80 | |
| Arcellx Common Stock (ACLX) | 0.8 | $10M | 150k | 69.55 | |
| Enanta Pharmaceuticals (ENTA) | 0.8 | $10M | 581k | 17.46 | |
| Nuvalent Inc-a (NUVL) | 0.7 | $9.7M | 129k | 75.09 | |
| Immunic (IMUX) | 0.7 | $9.6M | 7.3M | 1.32 | |
| Cg Oncology | 0.7 | $9.6M | 218k | 43.90 | |
| Inhibrx (INBX) | 0.7 | $9.4M | 268k | 34.96 | |
| Pharvaris N V (PHVS) | 0.7 | $9.3M | 402k | 23.11 | |
| Y Mabs Therapeutics (YMAB) | 0.7 | $9.3M | 571k | 16.26 | |
| Merus N V (MRUS) | 0.7 | $8.8M | 196k | 45.03 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $8.8M | 369k | 23.80 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.6 | $8.6M | 2.6M | 3.30 | |
| Immunovant (IMVT) | 0.6 | $8.6M | 265k | 32.31 | |
| Theratechnologies Com New (THTX) | 0.6 | $8.0M | 4.8M | 1.66 | |
| Natera (NTRA) | 0.6 | $8.0M | 87k | 91.46 | |
| Olema Pharmaceuticals (OLMA) | 0.6 | $7.4M | 658k | 11.32 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.5 | $7.2M | 783k | 9.13 | |
| Bausch Health Companies (BHC) | 0.5 | $7.1M | 670k | 10.61 | |
| Mannkind Corp Com New (MNKD) | 0.5 | $7.1M | 1.6M | 4.53 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.5 | $7.1M | 750k | 9.40 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $6.8M | 250k | 27.13 | |
| Fate Therapeutics (FATE) | 0.5 | $6.4M | 870k | 7.34 | |
| X4 Pharmaceuticals (XFOR) | 0.5 | $6.4M | 4.6M | 1.39 | |
| 4d Molecular Therapeutics In (FDMT) | 0.5 | $6.3M | 197k | 31.86 | |
| Miragen Therapeutics (VRDN) | 0.4 | $6.0M | 340k | 17.51 | |
| Janux Therapeutics (JANX) | 0.4 | $5.9M | 158k | 37.65 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $5.8M | 421k | 13.75 | |
| Viking Therapeutics (VKTX) | 0.4 | $5.5M | 67k | 82.00 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $4.7M | 566k | 8.32 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $4.6M | 386k | 11.86 | |
| Regulus Therapeutics (RGLS) | 0.3 | $4.5M | 1.6M | 2.88 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.3 | $3.8M | 153k | 24.90 | |
| Inspiremd (NSPR) | 0.2 | $3.3M | 1.4M | 2.37 | |
| Calcimedica Com New (CALC) | 0.2 | $3.3M | 784k | 4.16 | |
| Nkarta (NKTX) | 0.2 | $3.2M | 300k | 10.81 | |
| Dianthus Therapeutics (DNTH) | 0.2 | $3.0M | 100k | 30.00 | |
| Cervomed (CRVO) | 0.2 | $3.0M | 127k | 23.30 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $2.7M | 925k | 2.87 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.2 | $2.3M | 37k | 61.02 | |
| Evolus (EOLS) | 0.2 | $2.2M | 160k | 14.00 | |
| Arcutis Biotherapeutics (ARQT) | 0.2 | $2.2M | 225k | 9.91 | |
| Annexon (ANNX) | 0.2 | $2.1M | 292k | 7.17 | |
| Apogee Therapeutics (APGE) | 0.1 | $1.3M | 20k | 66.45 | |
| Transmedics Group (TMDX) | 0.1 | $1.2M | 17k | 73.94 | |
| Avita Therapeutics (RCEL) | 0.1 | $1.2M | 75k | 16.03 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $998k | 35k | 28.93 | |
| Denali Therapeutics (DNLI) | 0.1 | $964k | 47k | 20.52 | |
| CVRX (CVRX) | 0.1 | $883k | 49k | 18.21 | |
| The Beauty Health Company Com Cl A (SKIN) | 0.1 | $755k | 170k | 4.44 | |
| Amicus Therapeutics (FOLD) | 0.1 | $683k | 58k | 11.78 | |
| Tenaya Therapeutics (TNYA) | 0.0 | $639k | 122k | 5.23 | |
| Silk Road Medical Inc Common (SILK) | 0.0 | $183k | 10k | 18.32 | |
| Urogen Pharma (URGN) | 0.0 | $150k | 10k | 15.00 | |
| Liquidia Corporation Com New (LQDA) | 0.0 | $148k | 10k | 14.75 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $137k | 62k | 2.21 |
